FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Dr. Reddy's Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
Food & Beverages
Food & Beverages
FDA Commissioned Corps Officers on the Front Line of COVID-19 Response
Almost 400 FDA Commissioned Corps officers deployed to aid in response to the coronavirus public health emergency
FDA Offers Assurance About Food Safety and Supply for People and Animals During COVID-19
The U.S. food supply remains safe for both people and animals during the COVID-19 public health emergency.
FDA and EMA Collaborate to Facilitate SARS-CoV-2 Vaccine Development
FDA and EMA jointly chaired the first global regulators meeting to discuss regulatory strategies to facilitate the development of SARS-CoV-2 vaccines
Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products
Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components